Curi Bio unlocks novel workflows and critical human data to inform R&D decision-making. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and AI/ML-enabled insights, Curi Bio merges functional and analytical assessments for drug safety, efficacy, and potency.
Learn More About Curi Bio’s Platforms and Models
Structurally Mature & Predictive Human Engineered Cardiac, Skeletal Muscle, and Disease Models
Cutting Edge 2D & 3D Biosystems Technology to Improve Workflow & Screening Predictivity
Intuitive Software Solutions That Provide Easy Access to Information Rich Human-Relevant Data
Challenges in the Development of New Medicines
The Curi Engine™ Enables Drug Discovery for Human Diseases
With a focus on human disease models of contractile and excitable tissues, Curi Bio has developed a workflow that spans the preclinical drug development process.
Interested in increasing the predictive accuracy of your preclinical pipeline? Reach out to the Curi Bio team to inquire about partnership.